Histone deacetylase inhibitors enhance oncolytic herpes simplex virus therapy for malignant meningioma-Reference-Cited by-同舟云学术

Histone deacetylase inhibitors enhance oncolytic herpes simplex virus therapy for malignant meningioma

Published:2022-11 Issue: Volume:155 Page:113843
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Kawamura Yoichiro,Hua Lingyang,Gurtner Alessandra,Wong Ego,Kiyokawa Juri,Shah Nadia,Gorham Joshua,Wakimoto Hiroko,Rabkin Samuel D.,Martuza Robert L.,Wakimoto Hiroaki^ORCID

Funder

National Institutes of Health

Meningioma Mommas

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference48 articles.

1. CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2013-2017;Ostrom;Neuro Oncol.,2020

2. Genomic sequencing of meningiomas identifies oncogenic SMO and AKT1 mutations;Brastianos;Nat. Genet.,2013

3. Genomic analysis of non-NF2 meningiomas reveals mutations in TRAF7, KLF4, AKT1, and SMO;Clark;Science,2013

4. Hydroxyurea for recurrent surgery and radiation refractory high-grade meningioma;Chamberlain;J. Neurooncol.,2011

5. Temozolomide for treatment-resistant recurrent meningioma;Chamberlain;Neurology,2004

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in antitumour therapy with oncolytic herpes simplex virus combinations;Discover Oncology;2024-07-24

2. Changes in chromatin accessibility and transcriptional landscape induced by HDAC inhibitors in TP53 mutated patient-derived colon cancer organoids;Biomedicine & Pharmacotherapy;2024-04

3. Histone deacetylase inhibitor boosts anticancer potential of fusogenic oncolytic vaccinia virus by enhancing cell–cell fusion;Cancer Science;2023-11-30

4. Positioning SUMO as an immunological facilitator of oncolytic viruses for high-grade glioma;Frontiers in Cell and Developmental Biology;2023-10-04

5. Development and application of oncolytic viruses as the nemesis of tumor cells;Frontiers in Microbiology;2023-06-12